CertainT platform ensures traceability,
transparency and trust in responsible supply chains by tagging,
testing and tracking recycled PET
Applied DNA Sciences, Inc. (“Applied DNA,” “the Company,”
NASDAQ:APDN), has signed a multi-year license agreement with GHCL
Limited, a global manufacturer of home textiles, to provide
CertainT™ platform services in connection with source-verified,
polyethylene terephthalate (PET) and recycled PET (post consumer)
in select home textile products. PET is the clear plastic best
known for its use in water bottles, and is the most widely recycled
plastic in the world. GHCL will use Applied DNA’s CertainT platform
in connection with PET and/or recycled PET blended bed sheets,
pillowcases, and shams products sold in-store or online in the
United States. GHCL has also licensed Applied DNA’s CertainT
trademark for use on its products, as well as for promotional,
marketing and sales materials. The agreement provides for
guaranteed minimum annual revenues as well as trademark licensing
royalties to Applied DNA.
GHCL will use Applied DNA’s CertainT platform, a fully
integrated supply chain platform for verifying PET and recycled PET
authenticity from source to retail shelf. With this platform, GHCL
assures that any of its textile products using PET and recycled PET
will contain the original source raw materials. Applied DNA will
provide its patented and proprietary tagging, testing and tracking
services to GHCL as a CertainT licensee.
“As the need for sustainable and recyclable textiles continues
to increase in demand from our customers, we want to offer products
that provide true traceability that go beyond a paper document. In
these uncertain times, our customers deserve and expect certainty,”
stated Neeraj Jalan, Business Head, Home Textiles, for GHCL. “The
collaboration with Applied DNA provides a means to produce and
supply our customers with source-verified, recycled products, as
well as access to new authentication technologies in synthetic
fibers that Applied DNA develops over the course of our
relationship.”
As part of the platform, Applied DNA’s molecular tag is extruded
into recycled components that create recycled PET fiber, with no
impact to performance or quality of the fiber or filament yarns.
Thereafter, any piece of CertainT-tagged textiles can be
forensically authenticated by detecting the molecular tag in the
recycled PET fiber, ensuring its authenticity and origin.
“We bring ‘CertainT’ in uncertain times especially as many
brands and retailers need to fulfill their sustainability goals by
the year 2020,” said Dr. James Hayward, president and CEO of
Applied DNA. “The CertainT platform will help GHCL produce
innovative products utilizing an efficient and trusted traceability
system with a fair return. Differentiating their brand in the
marketplace through use of our CertainT trademark will signify to
consumers the products comply with our supply chain platform and
are verifiably made from recycled fibers.”
About GHCL
GHCL is a well-diversified group with footprints in Chemicals,
Textiles and Consumer Products segment. GHCL’s Textiles division is
a vertically integrated manufacturing facility with spinning,
wider-width weaving, continuous fabric processing, and cut &
sew facilities for manufacturing premium quality bed linen. GHCL is
one of India’s leading manufacturers of Home Textiles, with
in-house spinning unit having capability to manufacture multiple
varieties of 100% cotton and blended yarns at various
facilities.
GHCL is known as perennial innovators in bed linen category with
some of recent innovations in the category of ‘sheets’ which
include the PERFECT FIT, EASYSHEET, microTWILL, CELLIANT, EXL
Wrinkle Free Sheets, VERSATILE–Reversible Sheets, Soft Wash Percale
and Sustainable Fibre dyed sheets.
GHCL’s Home Textiles products are predominantly exported
worldwide to countries like United Kingdom, United States of
America, Australia, Canada, Germany and other European Union
countries as well.
About Applied DNA Sciences
Applied DNA is a provider of molecular technologies that enable
supply chain security, anti-counterfeiting and anti-theft
technology, product genotyping and DNA mass production for
diagnostics and therapeutics.
We make life real and safe by providing innovative,
molecular-based technology solutions and services that can help
protect products, brands, entire supply chains, and intellectual
property of companies, governments and consumers from theft,
counterfeiting, fraud and diversion. The proprietary DNA-based
“CertainT™” platform can be used to identify, tag, test, and track
products, to help assure authenticity, origin, traceability,
sustainability and quality of products. SigNature® DNA
describes the core technology ingredient that is at the heart of a
family of uncopyable, security and authentication solutions such as
SigNature® T and fiberTyping®, targeted toward textiles and
apparel, BackTrac™ and DNAnet®, for anti-theft and loss prevention,
and digitalDNA®, providing powerful track-and-trace. All provide a
forensic chain of evidence, and can be used to prosecute
perpetrators. Applied DNA Sciences is also engaged in the
large-scale production of specific DNA sequences using the
polymerase chain reaction.
Visit adnas.com for more information. Follow us
on Twitter and LinkedIn. Join our mailing
list.
Common stock listed on NASDAQ under the symbol APDN, and
warrants are listed under the symbol APDNW.
The statements made by APDN in this press release may be
“forward-looking” in nature within the meaning of the Private
Securities Litigation Act of 1995. Forward-looking statements
describe APDN’s future plans, projections, strategies and
expectations, and are based on assumptions and involve a number of
risks and uncertainties, many of which are beyond the control of
APDN. Actual results could differ materially from those projected
due to our short operating history, limited financial resources,
limited market acceptance, market competition and various other
factors detailed from time to time in APDN’s SEC reports and
filings, including our Annual Report on Form 10-K filed on December
6, 2016, and our subsequent quarterly reports on Form 10-Q filed on
February 9, 2017, and May 11, 2017 which are available at
www.sec.gov. APDN undertakes no obligation to update publicly any
forward-looking statements to reflect new information, events or
circumstances after the date hereof to reflect the occurrence of
unanticipated events, unless otherwise required by law.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20170711005149/en/
Investor:LHA Investor RelationsSanjay Hurry,
212-838-3777ormedia:CGPRAngie Mathews,
714-768-1140orprogram:MeiLin Wan,
631-240-8849orweb: www.adnas.comtwitter:
@APDN
Applied DNA Sciences (NASDAQ:APDN)
Historical Stock Chart
From Mar 2024 to Apr 2024
Applied DNA Sciences (NASDAQ:APDN)
Historical Stock Chart
From Apr 2023 to Apr 2024
